Full Text Full Text (PDF) Correction (v161,p1517) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Yonkers, K. A. Articles by Altshuler, L. Search for Related Content PubMed Citation Articles by Yonkers, K. A. Articles by Altshuler, L. Gender Bipolar Disorder Atypical Neuroleptics Conventional Neuroleptics Anticonvulsants ECT Lithium

Management of Bipolar Disorder During Pregnancy and the Postpartum Period

OBJECTIVE: Bipolar disorder affects 0.5%–1.5% of individuals in the United States. The typical age at onset is late adolescence or early adulthood, placing women at risk for episodes throughout their reproductive years. General guidelines for the treatment of bipolar disorder are available from the American Psychiatric Association, but additional issues arise when these guidelines are applied in the treatment of peripartum women. The authors summarize knowledge regarding the management of bipolar disorder during pregnancy and the postpartum period, with a focus on managing mania, hypomania, and the psychotic components of the illness. METHOD: An expert panel reviewed articles that address the management of bipolar disorder and the consequences of the use of mood stabilizers during pregnancy, and a consensus document was generated. RESULTS: The treatment of bipolar disorder in pregnant women involves significant challenges. Some mood stabilizers, e.g., sodium valproate and carbamazepine, are human teratogens. On the other hand, the teratogenicity associated with lithium may have been overestimated in the past. CONCLUSIONS: Since treatment can be managed most effectively if pregnancy is planned, clinicians should discuss the issue of pregnancy and its management with every bipolar disorder patient who has childbearing potential, regardless of future reproductive plans. Additional research should address the risks of disturbed sleep to pregnant and postpartum women with bipolar disorder, as well as structural and behavioral consequences to offspring when mood stabilizers are used during pregnancy. Longitudinal and cohort studies can promote these efforts. Given the rate of bipolar disorder in the general population, research efforts will need to be broad based and include multiple collaborating centers.

This article has been cited by other articles:

				T. L. Schonfeld, N. J. Amoura, and C. J. Kratochvil iPLEDGE Allegiance to the Pill: Evaluation of Year 1 of a Birth Defect Prevention and Monitoring System. J. Law Med. Ethics, March 1, 2009; 37(1): 104 - 117. [PDF]

				T. Munk-Olsen, T. M. Laursen, T. Mendelson, C. B. Pedersen, O. Mors, and P. B. Mortensen Risks and Predictors of Readmission for a Mental Disorder During the Postpartum Period Arch Gen Psychiatry, February 1, 2009; 66(2): 189 - 195. [Abstract] [Full Text] [PDF]

				S. Gentile Antipsychotic Therapy During Early and Late Pregnancy. A Systematic Review Schizophr Bull, September 11, 2008; (2008) sbn107v1. [Abstract] [Full Text] [PDF]

				A. C. Viguera, A. D. Emmerich, and L. S. Cohen Case 24-2008 -- A 35-Year-Old Woman with Postpartum Confusion, Agitation, and Delusions N. Engl. J. Med., July 31, 2008; 359(5): 509 - 515. [Full Text] [PDF]

				D. J. Newport, P. B. Pennell, M. R. Calamaras, J. C. Ritchie, M. Newman, B. Knight, A. C. Viguera, J. Liporace, and Z. N. Stowe Lamotrigine in Breast Milk and Nursing Infants: Determination of Exposure Pediatrics, July 1, 2008; 122(1): e223 - e231. [Abstract] [Full Text] [PDF]

				P. B. Pennell, L. Peng, D. J. Newport, J. C. Ritchie, A. Koganti, D. K. Holley, M. Newman, and Z. N. Stowe Lamotrigine in pregnancy: Clearance, therapeutic drug monitoring, and seizure frequency Neurology, May 27, 2008; 70(22_Part_2): 2130 - 2136. [Abstract] [Full Text] [PDF]

				N. ISAKOVICH and E. SMITH Delving Further Into Discontinuation Risk: Addressing the Use of Mood Stabilizers During Pregnancy Am J Psychiatry, May 1, 2008; 165(5): 646 - 646. [Full Text] [PDF]

				M. P. Freeman Bipolar Disorder and Pregnancy: Risks Revealed Am J Psychiatry, December 1, 2007; 164(12): 1771 - 1773. [Full Text] [PDF]

				A. C. Viguera, T. Whitfield, R. J. Baldessarini, D. J. Newport, Z. Stowe, A. Reminick, A. Zurick, and L. S. Cohen Risk of Recurrence in Women With Bipolar Disorder During Pregnancy: Prospective Study of Mood Stabilizer Discontinuation Am J Psychiatry, December 1, 2007; 164(12): 1817 - 1824. [Abstract] [Full Text] [PDF]

				Reference List for FOCUS Self-Assessment Examination PsychiatryOnline CME, October 10, 2007; 2007(3): 2 - 2. [Full Text]

				K. L. Wisner, C. Chambers, and D. K. Y. Sit Postpartum Depression: A Major Public Health Problem JAMA, December 6, 2006; 296(21): 2616 - 2618. [Full Text] [PDF]

				D. J. Newport, A. C. Viguera, A. J. Beach, J. C. Ritchie, L. S. Cohen, and Z. N. Stowe Lithium Placental Passage and Obstetrical Outcome: Implications for Clinical Management During Late Pregnancy Am J Psychiatry, November 1, 2005; 162(11): 2162 - 2170. [Abstract] [Full Text] [PDF]

				K. A. Yonkers, K. L. Wisner, Z. Stowe, E. Leibenluft, L. Cohen, L. Miller, R. Manber, A. Viguera, T. Suppes, and L. Altshuler Management of Bipolar Disorder During Pregnancy The Postpartum Period Focus, April 1, 2005; 3(2): 266 - 279. [Abstract] [Full Text] [PDF]

				Reviews of Note Journal Watch Psychiatry, August 4, 2004; 2004(804): 6 - 6. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us